RJA
TMO icon

Ross\Johnson & Associates’s Thermo Fisher Scientific TMO Stock Holding History

Ross\Johnson & Associates’s Portfolio TMO Stock Details TMO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-1
Closed -$579 – 334
2025
Q4 		$579 Buy
+1
New +$566 0.01% 138

Other funds holding TMO

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Ross\Johnson & Associates's TMO Position: Q1 2026 in Review

Ross\Johnson & Associates sold out of Thermo Fisher Scientific (TMO) in Q1 2026, closing a stake of 1 share — an estimated $579 sold.

Ross\Johnson & Associates first reported a position in TMO in Q4 2025 and held it in 1 quarter. The position peaked at $579 in Q4 2025. 2,590 funds tracked by Wall St. Rank hold TMO as of Q1 2026.

  • Ross\Johnson & Associates reported no remaining Thermo Fisher Scientific position as of Q1 2026 after selling out during the quarter.
  • Ross\Johnson & Associates sold 1 Thermo Fisher Scientific share in Q1 2026, an estimated $579.
  • Ross\Johnson & Associates first reported a position in Thermo Fisher Scientific in Q4 2025 and held it in 1 quarter.
  • Ross\Johnson & Associates's Thermo Fisher Scientific position peaked at $579 in Q4 2025.
  • 2,590 funds tracked by Wall St. Rank held Thermo Fisher Scientific as of Q1 2026.

Based on Ross\Johnson & Associates's 13F filing for Q1 2026, filed 8 May 2026.